Covered recipient · General Payments record
CHRISTOPHER DRUMM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,078.53
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.32 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $218.51 | 11 |
| ABBVIE INC. | $86.40 | 5 |
| Lilly USA, LLC | $38.56 | 2 |
| PFIZER INC. | $37.99 | 2 |
| Abbott Laboratories | $32.27 | 2 |
| Alkermes, Inc. | $28.80 | 1 |
| Acerta Pharma LLC | $27.36 | 2 |
| Dynavax Technologies Corporation | $23.47 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.10 | 1 |
| Amgen Inc. | $14.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.65 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125309858 | CMS |
| Abbott Laboratories | $16.62 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125309860 | CMS |
| ABBVIE INC. | $13.63 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660820 | CMS |
| ABBVIE INC. | $18.50 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660822 | CMS |
| ABBVIE INC. | $16.17 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660824 | CMS |
| ABBVIE INC. | $22.11 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660826 | CMS |
| ABBVIE INC. | $15.99 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660828 | CMS |
| Alkermes, Inc. | $28.80 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120492393 | CMS |
| Amgen Inc. | $14.86 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117242110 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.71 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104445147 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.65 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104340558 | CMS |
| Dynavax Technologies Corporation | $23.47 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082148883 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.10 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101826596 | CMS |
| Lilly USA, LLC | $14.15 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136112208 | CMS |
| Lilly USA, LLC | $24.41 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136122180 | CMS |
| Novo Nordisk Inc | $10.13 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569144 | CMS |
| Novo Nordisk Inc | $23.07 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097810174 | CMS |
| Novo Nordisk Inc | $22.47 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097722212 | CMS |
| Novo Nordisk Inc | $17.59 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900661 | CMS |
| Novo Nordisk Inc | $19.46 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097434398 | CMS |
| Novo Nordisk Inc | $20.22 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096732635 | CMS |
| Novo Nordisk Inc | $22.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097725382 | CMS |
| Novo Nordisk Inc | $21.49 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096711230 | CMS |
| Novo Nordisk Inc | $6.49 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096758760 | CMS |
| Novo Nordisk Inc | $22.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096608550 | CMS |
| Novo Nordisk Inc | $32.26 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096636055 | CMS |
| PFIZER INC. | $17.57 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131258618 | CMS |
| PFIZER INC. | $20.42 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131228512 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.